Table 2.
The frequency of antimicrobial resistance in 120 S. aureus isolates obtained from clinical specimens
| Antibiotics | MSSA (n=35) n (%) |
MRSA (n=85) n (%) |
All (n=120) n (%) |
|||
|---|---|---|---|---|---|---|
| S | R | S | R | S | R | |
| penicillin | 2(5.7) | 33(94.3) | 6(7.1) | 79(92.9) | 8(6.7) | 112(93.3) |
| kanamycin | 17(48.6) | 18(51.4) | 10(11.8) | 75(88.2) | 27(22.5) | 93(77.5) |
| gentamicin | 21(60) | 14(40) | 9(10.6) | 76(89.4) | 30(25) | 90(75) |
| ciprofloxacin | 23(65.7) | 12(34.3) | 12(14.1) | 73(85.9) | 35(29.2) | 85(70.8) |
| tetracycline | 21(60) | 14(40) | 15(17.6) | 70(82.4) | 36(30) | 84(70) |
| amikacin | 27(77.1) | 8(22.9) | 11(12.9) | 74(87.1) | 38(31.7) | 82(68.3) |
| tobramycin | 29(82.9) | 6(17.1) | 20(23.5) | 65(76.5) | 49(40.8) | 71(59.2) |
| erythromycin | 29(82.9) | 6(17.1) | 21(24.7) | 64(75.3) | 50(41.7) | 70(58.3) |
| clindamycin | 30(85.7) | 5(14.3) | 32(37.6) | 53(62.4) | 62(51.7) | 58(48.3) |
| ceftriaxone | 30(85.7) | 5(14.3) | 35(41.2) | 50(58.8) | 65(54.2) | 55(45.8) |
| trimetoprim-sulfamethoxazole | 33(94.3) | 2(5.7) | 53(62.4) | 32(37.6) | 86(71.7) | 34(28.3) |
| mupirocin | 35(100) | 0(0) | 55(64.7) | 30(35.3) | 90(75) | 30(25) |
| quinupristin-dalfopristin | 31(88.6) | 4(11.4) | 74(87.1) | 11(12.9) | 105(87.5) | 15(12.5) |
| linzolid | 35(100) | 0(0) | 85(100) | 0(0) | 120(100) | 0(0) |
| teicoplanin | 35(100) | 0(0) | 85(100) | 0(0) | 120(100) | 0(0) |
| vancomycin | 35(100) | 0(0) | 85(100) | 0(0) | 120(100) | 0(0) |